Antonio R. Pera - 21 May 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Reporting relationship: Director
Issuer ticker: ANIP
Reported as of: 21 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 21:08:22 UTC
Prior SEC filing: 04 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Antonio R. Pera, by attorney-in-fact Meredith W. Cook

Key filing fact

Antonio R. Pera filed Form 4 for ANI PHARMACEUTICALS INC (ANIP) on 10 Jun 2026.

Key facts

This page summarizes Antonio R. Pera's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jun 2026, 21:08.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001689325 Primary reporting owner

Relationship: Director
Address: C/O ANI PHARMACEUTICALS, INC., 104 CARNEGIE CENTER, SUITE 300, PRINCETON
Signature: /s/ Antonio R. Pera, by attorney-in-fact Meredith W. Cook
Signature date: 10 Jun 2026

Shares, units, or other non-derivative securities reported in this filing.

ANIP transaction

Award

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Represents a restricted stock award that will vest in full on May 21, 2027.